Use of thymosin in the treatment of primary immunodeficiency diseases and cancer.
D000818:Animals; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular / Q000187:drug effects; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000276:immunology; D007223:Infant; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D008934:Mitogens / Q000494:pharmacology; D009369:Neoplasms / Q000188:drug therapy* / Q000276:immunology; D013947:Thymosin / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D013949:Thymus Extracts / Q000627:therapeutic use*
D008934:Mitogens; D013949:Thymus Extracts; D013947:Thymosin